Last €125.30 EUR
Change Today -0.95 / -0.75%
Volume 552.0K
OR On Other Exchanges
Symbol
Exchange
OTC US
OTC US
EN Paris
BrsaItaliana
Mexico
As of 11:36 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by L'OREAL (OR) in the last 6 months

Announced 06/18/14
NYX, Los Angeles, Inc.
Merger/Acquisition

L'Oreal SA (ENXTPA:OR) signed an agreement to acquire NYX, Los Angeles, Inc. from HCP & Company and others on June 17, 2014. In 2013, NYX generated sales of $72 million. NYX Cosmetics will continue to operate out of their Los Angeles headquarters under the brand’s current leadership team. NYX will become part of the Consumer Products Division of L’Oréal. The deal is subject to regulatory approval. As of June 30, 2014, the transaction was granted early termination of ...
Read More


OR's price was unchanged after the transaction was announced on 06/18/14.
Investor / Buyer
L'Oreal SA
Creditor / Lender
HCP & Company
Financial Advisor
Piper Jaffray Companies
Legal Advisor
Morgan, Lewis & Bockius LLP
 
Announced 04/17/14
12.12B for L'Oreal SA
Buyback

L'Oreal SA announces a share repurchase program. Under the program, the company will repurchase its own shares such that its holding in treasury does not exceed 10% of its issued share capital. The shares will be repurchased at a purchase price per share that may not be greater than €200 per share and the amount allocated for the repurchase is €12,120 million. The purchase of these shares may be carried out by any means, on one or more occasions, on or off the stock ...
Read More


OR's price was unchanged after the transaction was announced on 04/17/14.
 
Announced 02/11/14
L'Oreal SA
Buyback

L'Oreal SA (ENXTPA:OR) announces a share repurchase program. Under the program, the company will repurchase up to 48,500,000 shares, representing 8% stake from Nestlé S.A. (SWX:NESN). The repurchases will be made €3,400 million in cash and 50% stake in Galderma which carries an enterprise value of €3,100 million. The shares repurchases will be cancelled. The buyback will be exclusively financed with L'Oréal's available cash and through the issuance of commercial paper.The ...
Read More


OR's price was unchanged after the transaction was announced on 02/11/14.
 
Announced 02/11/14
2.74B for Galderma Pharma SA
Merger/Acquisition

Nestlé S.A. (SWX:NESN) has signed an agreement to acquire remaining 50% stake Galderma Pharma SA from L'Oreal SA (ENXTPA:OR) for €2.7 billion on February 10, 2014. L'Oréal will buyback 27.3 million L'Oréal shares held by Nestlé, in cash for an amount of €3.4 billion. Galderma reoprted sales of CHF 2 billion (€1.6 billion) in 2013. In order to reflect the change of Nestlé's stake in L'Oréal's governance, the number of Nestlé representatives on L'Oréal's Board of Directors ...
Read More


OR's price was unchanged after the transaction was announced on 02/11/14.
Investor / Buyer
Nestlé S.A.
Creditor / Lender
L'Oreal SA
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OR:FP €125.30 EUR -0.95

OR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bristol-Myers Squibb Co $48.37 USD +0.45
Colgate-Palmolive Co $69.37 USD -0.2829
eBay Inc $50.23 USD -0.70
GlaxoSmithKline PLC 1,572 GBp +15.50
LVMH Moet Hennessy Louis Vuitton SA €139.35 EUR -0.15
View Industry Companies
 

Industry Analysis

OR

Industry Average

Valuation OR Industry Range
Price/Earnings 25.8x
Price/Sales 3.3x
Price/Book 3.3x
Price/Cash Flow 25.7x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact L'OREAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.